Published in Hepatology on December 01, 1997
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol (2010) 2.26
GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepat (2009) 1.41
GB virus C: the good boy virus? Trends Microbiol (2012) 1.39
Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol (2000) 1.29
Effect of primer selection on estimates of GB virus C (GBV-C) prevalence and response to antiretroviral therapy for optimal testing for GBV-C viremia. J Clin Microbiol (2006) 0.99
GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates. J Immunol (2010) 0.99
Role of GB virus C in modulating HIV disease. Expert Rev Anti Infect Ther (2012) 0.95
Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication. Virology (2012) 0.90
Characterization of an immunodominant antigenic site on GB virus C glycoprotein E2 that is involved in cell binding. J Virol (2006) 0.89
GB virus C/hepatitis G virus (GBV-C/HGV): still looking for a disease. Int J Exp Pathol (2000) 0.88
Identification of hepatitis G virus particles in human serum by E2-specific monoclonal antibodies generated by DNA immunization. J Virol (1998) 0.84
Downregulation of Cytokines and Chemokines by GB Virus C After Transmission Via Blood Transfusion in HIV-Positive Blood Recipients. J Infect Dis (2014) 0.83
Molecular evidence of mother-to-infant transmission of hepatitis G virus among women without known risk factors for parenteral infections. J Clin Microbiol (1999) 0.82
Transmission of GB virus type C via transfusion in a cohort of HIV-infected patients. J Infect Dis (2012) 0.81
Past and present hepatitis G virus infections in areas where hepatitis C is highly endemic and those where it is not endemic. J Clin Microbiol (1998) 0.79
Interactions Between GB Virus Type C and HIV. Curr Infect Dis Rep (2002) 0.79
HIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected]. PLoS One (2013) 0.79
Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors. J Clin Microbiol (2000) 0.77
Lower hepatitis G virus infection prevalence compared to hepatitis B and C virus infection prevalences. Dig Dis Sci (2000) 0.75
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet (2010) 13.59
High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med (2001) 12.49
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol (1992) 6.09
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science (1996) 5.55
Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A (1991) 5.51
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science (2000) 5.49
Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 4.94
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A (1996) 4.82
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med (1991) 4.79
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology (1990) 4.43
Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med (1991) 4.24
Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol (1993) 4.13
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J Clin Microbiol (1999) 3.88
Rotavirus isolate WI61 representing a presumptive new human serotype. J Clin Microbiol (1987) 3.58
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A (1994) 3.56
Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med (1975) 3.31
Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science (1984) 3.20
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol (1994) 3.06
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med (1992) 3.01
Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med (1990) 2.99
Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. J Immunol (1971) 2.98
Microtiter solid-phase radioimmunoassay for hepatitis B antigen. Appl Microbiol (1973) 2.96
Transmissible agent in non-A, non-B hepatitis. Lancet (1978) 2.78
Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science (1979) 2.78
Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis (1987) 2.68
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med (1976) 2.67
Strengthening of horizontal cortical connections following skill learning. Nat Neurosci (1998) 2.66
What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors? Lancet (1989) 2.63
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology (2001) 2.62
Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology (1998) 2.62
Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med (1995) 2.61
Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet (1997) 2.54
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang (2005) 2.47
Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol (1999) 2.41
Clinical and serological analysis of transfusion-associated hepatitis. Lancet (1975) 2.41
Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology (2001) 2.38
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann Intern Med (1978) 2.29
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med (1986) 2.27
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology (1991) 2.25
Further studies on a "new" human isoprecipitin system (Australia antigen). Blood (1966) 2.16
Justification of the 4-mmol/l lactate threshold. Int J Sports Med (1985) 2.15
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study. Hepatology (2001) 2.13
High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients. Lancet (1992) 2.06
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel. N Engl J Med (1973) 2.05
Early events in hepatitis C virus infection of chimpanzees. Proc Natl Acad Sci U S A (1990) 2.04
G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion (1997) 1.96
Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene (2006) 1.94
Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med (1984) 1.93
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med (1991) 1.91
Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology (2000) 1.87
Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. Eur Respir J (1994) 1.87
Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med (1996) 1.81
SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology (2001) 1.80
Microtubule-dependent control of cell shape and pseudopodial activity is inhibited by the antibody to kinesin motor domain. J Cell Biol (1993) 1.79
Nonsurgical treatment of duodenal perforation by endoscopic repair using a clipping device. Gastrointest Endosc (1999) 1.72
Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol (1999) 1.72
Management of the asymptomatic carrier of the hepatitis-associated (Australia antigen. Tentative considerations of the clinical and public-health aspects. N Engl J Med (1971) 1.71
Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood. Lancet (1985) 1.70
Identification of Mycoplasma incognitus infection in patients with AIDS: an immunohistochemical, in situ hybridization and ultrastructural study. Am J Trop Med Hyg (1989) 1.70
The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol (1992) 1.67
Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma. J Clin Invest (1993) 1.66
Expression and characterization of HIV type 1 envelope protein associated with a broadly reactive neutralizing antibody response. AIDS Res Hum Retroviruses (1999) 1.66
Serological pattern "anti-HBc alone": report on a workshop. J Med Virol (2000) 1.65
Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. Proc Natl Acad Sci U S A (1989) 1.64
Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med (1972) 1.64
Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood (1990) 1.64
Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy? Br J Cancer (2007) 1.61
The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang (2010) 1.60
In vivo measurement of the elastic modulus of the human periodontal ligament. Med Eng Phys (2001) 1.59
Serial transmission in rhesus monkeys of an agent related to hepatitis-associated antigen. J Infect Dis (1972) 1.57
Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria. Diabetologia (2004) 1.56
Transmission of and liver injury by TT virus in patients on maintenance hemodialysis. J Gastroenterol (1999) 1.55
Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol (1984) 1.55
Subtyping of hepatitis-associated antigen (HB-Ag); simplified technique with counterelectrophoresis. J Immunol (1972) 1.54
The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med (1979) 1.54
Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis (1996) 1.53
Impaired cough reflex in patients with recurrent pneumonia. Thorax (2003) 1.53
Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis. Thromb Haemost (1996) 1.51
Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective. Semin Liver Dis (1986) 1.51
The cloning and clinical implications of HGV and HGBV-C. N Engl J Med (1996) 1.50
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. Hepatology (1998) 1.50
The UL84 protein of human cytomegalovirus acts as a transdominant inhibitor of immediate-early-mediated transactivation that is able to prevent viral replication. J Virol (1997) 1.49
Successful living-related partial liver transplantation to an adult patient. Lancet (1994) 1.47